Abstract
There are mainly two types of short RNAs that target complementary messengers in animals: small interfering RNAs and micro-RNAs. Both are produced by the cleavage of double-stranded RNA precursors by Dicer, a member of the Rnase III family of double-stranded specific endonucleases, and both guide the RNA-induced silencing complex to cleave specifically RNAs sharing sequence identity with them. In designing a particular RNA interference (RNAi), it is important to identify the sense/antisense combination that provides the most potent suppression of the target mRNA, and several rules have been established to give >90% gene expression inhibition. RNAi technology can be directed against cancer using a variety of strategies. These include the inhibition of overexpressed oncogenes, blocking cell division by interfering with cyclin E and related genes or promoting apoptosis by suppressing antiapoptotic genes. RNAi against multidrug resistance genes or chemoresistance targets may also provide useful cancer treatments. Studies investigating these approaches in preclinical models are also reviewed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Napoli C, Lemieux C, Jorgensen R . Introduction of a chimeric chalcone synthase gene into Petunia results in reversible co-suppression of homologous genes in trans. Plant Cell. 1990;2:279–289.
Van der Krol AR, Mur LA, Beld M, et al. Flavonoid genes in Petunia: addition of a limited number of gene copies may lead to a suppression of gene expression. Plant Cell. 1990;2:291–299.
Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–811.
Tuschl T, Zamore PD, Lehman R, et al. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 1999;15:3191–3197.
Hammond S, Bernstein E, Beach D, et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature. 2000;404:293–296.
Nicanen A, Haley B, Zamore PD . ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell. 2001;107:309–321.
Schwarz DS, Hutvagner G, Haley B, et al. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol Cell. 2002;10:537–548.
Elbashir SM, Lendeckel W, Tuschi T . RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001;15:188–200.
Dalmay T, Hamilton A, Rudd S, et al. An RNA dependent RNA polymerase in Arabidopsis is required for posttranscriptional gene silencing mediated by a transgene but not by a virus. Cell. 2000;101:543–553.
Cogoni C, Macino G . Gene silencing in Neurospora crassa requires a protein homologous to RNA-dependent RNA polymerase. Nature. 1999;399:166–169.
Smardon A, Spoerke JM, Stacey SC, et al. EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C. elegans. Curr Biol. 2000;10:169–178.
Li H, Li WX, Ding SW . Induction and suppression of RNA silencing by an animal virus. Science. 2002;296:1319–1321.
Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853–858.
Lau NC, Lim LP, Weinstein EG, et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001;294:858–862.
Bartel DP . MicroRNAs: genomics, biogenesis mechanism, and function. Cell. 2004;116:281–297.
Bartel B, Bartel DP . MicroRNAs: at the root of plant development? Plant Physiol. 2003;132:709–717.
Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83–86.
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101:2999–3004.
Basyuk E, Suavet F, Doglio A, et al. Human let-7 stem-loop precursors harbor features of RNase III cleavage products. Nucleic Acid Res. 2003;31:6593–6597.
Lund E, Güttinger S, Calado A, et al. Nuclear export of microRNA precursors. Science. 2004;303:95–98.
Yi R, Qin Y, Macara IG, et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003;17:3011–3016.
Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415–419.
Zamore PD, Tuschl T, Sharp PA, et al. RNAi:double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 2000;101:25–33.
Bernstein E, Caudy AA, Hammond SM, et al. Role of a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001;409:295–296.
Zhang H, Kolb FA, Brondani V, et al. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J. 2002;21:5875–5885.
Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83–86.
Zeng Y, Yi R, Cullen BR . MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA. 2003;100:9779–9784.
Doench JG, Peterson CP, Sharp PA . siRNAs can function as miRNAs. Genes Dev. 2003;17:438–442.
Pal-Bhadra M, Leibovitch BA, Sumit GG, et al. Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science. 2004;303:669–672.
Verdel A, Jia S, Gerber S, et al. RNAi-mediated targeting of heterochromatin by the RITS complex. Science. 2004;303:672–676.
Aukerman MJ, Sakai H . Regulation of flowering time and floral organ identity by a MicroRNA and its APETALA2-like target genes. Plant Cell. 2003;10:10.
Marathe R, Anandalakshmi R, Smith TH, et al. RNA viruses as inducers, suppressors and targets of post-transcriptional gene silencing. Plant Mol Biol. 2000;43:295–306.
Vance V, Vaucheret H . RNA silencing in plants — defense and counterdefense. Science. 2001;292:2277–2280.
Waterhouse PM, Helliwell CA . Exploring plant genomes by RNA-induced gene silencing. Nat Rev Genet. 2003;4:29–38.
Lee YS, Nakahara K, Pham JW, et al. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell. 2004;117:69–81.
Finnegan EJ, Margis R, Waterhouse PM . Posttranscriptional gene silencing is not compromised in the Arabidopsis CARPEL FACTORY (DICER-LIKE1) mutant, a homolog of Dicer-1 from Drosophila. Curr Biol. 2003;13:236–240.
Pham JW, Pellino JL, Lee YS, et al. A Dicer-2-dependent 80S complex cleaves targeted mRNAs during RNAi in Drosophila. 2004;117:83–94.
Sijen T, Plasterk RH . Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi. Nature. 2003;426:310–314.
Reinhart BJ, Slack FJ, Basson M, et al. The 21 nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403:901–906.
Brennecke J, Hipfner DR, Stark A, et al. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell. 2003;113:25–36.
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101:2999–3004.
Ambros V, Lee RC . Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol. 2004;265:131–158.
Kuwabara T, Hsieh J, Nakashima K, et al. A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell. 2004;116:779–793.
Novina CD, Sharp PA . The RNAi revolution. Nature. 2004;430:161–164.
Bridge AJ, Pebernard S, Ducraux A, et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet. 2003;34:363–364.
Sledz CA, Holko M, de Veer MJ, et al. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 2003;5:834–839.
Stojdl DF, Lichty B, Knowles S, et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med. 2000;6:821–825.
Yoshinari K, Miyagishi M, Taira K . Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acid Res. 2004;32:691–699.
Khvorova A, Reynolds A, Jayasena SD . Functional siRNAs and miRNAs exhibit strand bias. Cell. 2003;115:209–216.
Schwarz DS, Hutvagner G, Du T, et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003;115:199–208.
Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interference. Nat Biotechnol. 2004;22:326–330.
Ui-Tei K, Naito Y, Takahashi F, et al. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 2004;32:936–948.
Meister G, Landthaler M, Dorsett Y, et al. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA. 2004;10:544–550.
Dunoyer P, Lecellier CH, Parizotto EA, et al. Probing the microRNA and small interfering RNA pathways with virus-encoded suppressors of RNA silencing. Plant Cell. 2004;5:1235–1250.
Zamore PD . Plant RNAi: how a viral silencing suppressor inactivates siRNA. Curr Biol. 2004;14:R198–R200.
Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–498.
Kim DH, Longo M, Han Y, et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol. 2004;22:321–325.
Semizarov D, Frost L, Sarthy A, et al. Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci USA. 2003;100:6347–6352.
Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci USA. 2004;101:1892–1897.
Brummelkamp TR, Bernards R, Agami R . A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296:550–553.
Sui G, Soohoo C, Affar E, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA. 2002;99:5515–5520.
Shinagawa T, Ishii S . Generation of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter. Genes Dev. 2003;17:1340–1345.
Brummelkamp TR, Bernards R, Agami R . Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell. 2002;2:243–247.
Devroe E, Silver PA . Retrovirus-delivered siRNA. BMC Biotechnol. 2002;2:15–20.
de Felipe P, Izquierdo M . Tricistronic and tetracistronic retroviral vectors for gene transfer. HumGene Ther. 2000;11:1921–1931.
Hawkins LK, Lemoine NR, Kirn D . Oncolytic biotherapy: a novel therapeutic platform. Lancet Oncol. 2002;3:17–26.
Freytag SO, Khil M, Stricker H, et al. Phase I study of replication–competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res. 2002;62:4968–4976.
Carette JE, Overmeer RM, Schagen FHE, et al. Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells. Cancer Res. 2004;64:2663–2667.
Rubinson DA, Dillon CP, Kwiatkowski AV, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 2003;33:401–406.
Hommel JD, Sears RM, Georgescu D, et al. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med. 3003;9:1539–1544.
Van Den Haute C, Eggermont K, Nuttin B, et al. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum Gene Ther. 2003;14:1799–1807.
Hingorani SR, Jacobetz MA, Robertson GP, et al. Suppression of BRAFV599E in human melanoma abrogates transformation. Cancer Res. 2003;63:5198–5202.
Sumimoto H, Miyagishi M, Miyoshi H, et al. Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference. Oncogene. 2004;24 advanced publication 21 June.
Mitsushita J, Lambeth JD, Kamata T . The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res. 2004;64:3580–3585.
Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–954.
Lyons JF, Wilhelm S, Hibner B, et al. Discovery of a novel Raf kinase inhibitor. Endocr-Relat Cancer. 2001;8:219–225.
Menendez JA, Vellon L, Mehmi I, et al. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci USA. 2004, www.pnas.org/cgi/doi/10.1073/pnas.0403390101 online early edition.
Li K, Lin S, Brunicardi FC, et al. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma. Cancer Res. 2003;63:3593–3597.
Martin-Lluesma S, Stucke VM, Nigg EA . Role of Hec1 in spindle checkpoint signalling and kinetochore recruitment of Mad1/Mad2. Science. 2002;297:2267–2270.
Chen Y, Riley DJ, Zheng L, et al. Phosphorylation of the mitotic regulator protein Hec1 by Nek2 kinase is essential for faithful chromosome segregation. J Biol Chem. 2002;277:49408–49416.
Cohen M, Feinstein N, Wilson KL, et al. Nuclear pore protein gp210 is essential for viability in Hela cells and Caenorhabditis elegans. Mol Biol Cell. 2003;14:4230–4237.
Duensing A, Medeiros F, McConarty B, et al. Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene. 2004;23:3999–4006.
Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advance gastrointestinal stromal tumors. N Engl J Med. 2002;347:472–480.
Wilda M, Fuchs U, Wossmann W, et al. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene. 2002;21:5716–5724.
Scherr M, Battmer K, Winkler T, et al. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood. 2003;101:1566–1569.
Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett. 2003;545:144–150.
Duxbury MS, Ito H, Zinner MJ, et al. RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine. Oncogene. 2004;23:1539–1548.
Daniel JC, Cao X, Miller SD, et al. RNA interference of the bcl-xl gene in esophageal adenocarcinoma. J Surg Res. 2003;114:278.
Crnkovic-Mertens I, Hoppe-Seyler F, Butz K . Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene. 2003;22:8330–8336.
Altieri DC . Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene. 2003;22:8581–8589.
Carvalho A, Carmena M, Sambade C . Survivin is required for stable checkpoint activation in taxol-treated Hela cells. J Cell Sci. 2003;116:2987–2998.
Ling X, Li F . Silencing of antiapoptotic and surviving gene by multiple approaches of RNA interference technology. Biotechniques. 2004;36:450–460.
Brower V . Tumor angiogenesis — new drugs on the block. Nat Biotechnol. 1999;17:963–968.
Jansen M, de Witt Hamer PC, Witmer AN, et al. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Rev. 2004;45:143–163.
Novak K . Angiogenesis inhibitors revised and revived at AACR. American Association for Cancer Research. Nat Med. 2002;8:427.
Filleur S, Volpert O, Degeorges A, et al. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects. Genes Dev. 2001;15:1373–1382.
Filleur S, Courtin A, Ait-Si-Ali S, et al. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res. 2003;63:3919–3922.
Cullen BR, Lomedico PT, Ju G . Transcriptional interference in avian retroviruses-implications for the promoter insertion model of leukaemogenesis. Nature. 1984;307:241–245.
Emmerman M, Temin HM . High-frequency deletion in recovered retrovirus vector containing endogenous DNA with promoters. J Virol. 1984;50:42–49.
Emmerman M, Temin HM . Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 1984;39:459–467.
Emmerman M, Temin HM . Quantitative analysis of gene suppression in retrovirus vectors. Mol Cell Biol. 1986;6:792–800.
Emmerman M, Temin HM . Comparison of promoter suppression in avian and murine retrovirus vectors. Nucleic Acids Res. 1986;14:9381–9396.
Clark EA, Golub TR, Lander ES, et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000;406:532–535.
Amatschek S, Koenig U, Auer H, et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res. 2004;64:844–856.
Hafkemeyer P, Brinkmann U, Gottesman M, et al. Apoptosis induced by Pseudomonas exotoxin: a sensitive and rapid marker for gene delivery in vivo. Hum Gene Ther. 1999;10:923–934.
Brinkmann U, Pastan I . Immunotoxins against cancer. Biochim Biophs Acta. 1994;1198:27–45.
Martín V, Cortés ML de Felipe P, et al. Cancer gene therapy by thyroid-hormone mediated expression of toxin genes. Cancer Res. 2000;60:218–3224.
Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995;268:1766–1769.
No D, Yao TP, Evans RM . Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA. 1996;93:3346–3351.
Gupta S, Schoer R, Egan JE, et al. Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci USA. 2004;101:1927–1932.
Gupta S, Schoer R, Egan JE, et al. Inducible, reversible and stable RNA interference in mammalian cells. Proc Natl Acad Sci USA. 2004;101:1927–1932.
Van Craenenbroeck K, Vanhoenacker P, Leysen JE, et al. Evaluation of the tetracycline- and ecdysone-inducible systems for expression of neurotransmitter receptors in mammalian cells. Eur J Neurosci. 2001;14:968–976.
Izquierdo M, Cortés ML, de Felipe P, et al. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther. 1995;2:66–69.
Cortés ML, de Felipe P, Martín V, et al. Successful use of a plant gene in the treatment of cancer in vivo. Gene Ther. 1998;5:1499–1507.
Cortés ML, García-Escudero V, Hughes M, et al. The cyanide bystander effect of the linamarase/linamarin killer-suicide gene therapy system. J Gene Med. 2002;4:1–8.
Izquierdo M, Martín V, de Felipe P, et al. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy. Gene Ther. 1996;3:491–495.
Ram Z, Culver KW, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med. 1997;3:1354–1361.
Brummelkamp TR, Bernards R . New tools for functional mammalian cancer genetics. Nat Rev Cancer. 2003;3:781–789.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Izquierdo, M. Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther 12, 217–227 (2005). https://doi.org/10.1038/sj.cgt.7700791
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700791